Los Angeles, CA -- (SBWIRE) -- 02/05/2019 -- QY Research has come up with a newly published report on global Argatroban market in its database that provides an in-depth analysis of the key market insights, its future trends, and developments, profiles of leading players, key restraints and drivers, segmentation and forecasting. The report highlights the Argatroban market size and CAGR of the important segments, thus providing quick relevant information about the global Argatroban market.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
In the last several years, the global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, the global capacity of Argatroban reduced to 34786 grams.
Get PDF Document of the Argatroban Market report https://www.qyresearch.com/sample-form/form/955633/global-argatroban-industry-analysis-report
from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with an average growth rate of -9% in the coming five years.
Japan is the still the largest supplier of argatroban with the production market share of 35% and the consumer market share of 22% in 2015.
The price of argatroban is relatively expensive. The largest consumers have developed countries with high income. The USA occupied a market share of 34%. The second place in Europe, following North America with the consumer market share of 22% in 2015.
China has few companies entering the market with a production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.
Initially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen, and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human's bodies and fierce competition from other substitutes, it sales far less than another thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.
The global Argatroban market is valued at 84 million US$ in 2018 is expected to reach 23 million US$ by the end of 2025, growing at a CAGR of -15.0% during 2019-2025.
Major Key Manufacturers of Argatroban Market are:
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
Argatroban market includes market size, segmentation data and geographical analysis of market growth trends, leading companies, and microeconomic information.
Major Classification as follows:
Major Application as follows:
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Click to view Tables, Charts, Figures, TOC, and Companies Mentioned in the global Argatroban market Report @ https://www.qyresearch.com/index/detail/955633/global-argatroban-industry-analysis-report
Reasons to buy this report:
The Argatroban report is designed in a method that assists clients to acquire a complete knowledge of the overall market scenario and the important sectors.
This report consists of a detailed overview of Argatroban market dynamics and comprehensive research.
Explore further Argatroban market opportunities and identify high potential categories based on detailed volume and value analysis.
Detail information on competitive landscape, Argatroban recent market trends and changing technologies that can be useful for the companies which are competing in the Argatroban industry.
Gaining knowledge about Argatroban market competitive landscape based on detailed brand share analysis to plan an effective market positioning.
Get Customized Report in your Inbox within 24 hours @ https://www.qyresearch.com/request-discount/form/955633/global-argatroban-industry-analysis-report
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.